{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:36:19Z","timestamp":1787495779433,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["22\/12027-0"],"award-info":[{"award-number":["22\/12027-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/04275\\u20139"],"award-info":[{"award-number":["2024\/04275\\u20139"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tips.2026.01.012","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:11:05Z","timestamp":1773263465000},"page":"351-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Formyl peptide receptors as therapeutic targets in eye disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Rafael Andr\u00e9","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shama","family":"Parween","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane D.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Natalia","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.01.012_bb0005","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1111\/bph.17334","article-title":"Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles","volume":"182","author":"Pajonczyk","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2026.01.012_bb0010","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1111\/bph.17310","article-title":"Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists","volume":"181","author":"Peng","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2026.01.012_bb0015","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400656R","article-title":"LL37\/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy","volume":"38","author":"Lou","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2026.01.012_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10753-021-01555-3","article-title":"Crosstalk between RPE cells and choroidal endothelial cells via the ANXA1\/FPR2\/SHP2\/NLRP3 inflammasome\/pyroptosis axis promotes choroidal neovascularization","volume":"45","author":"Zhu","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.tips.2026.01.012_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.66.11.29","article-title":"Inhibiting the uPA\/uPAR pathway affords photoreceptor resilience and preserves retinal function in a mouse model of retinitis pigmentosa","volume":"66","author":"Amato","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tips.2026.01.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104553","article-title":"FPR2 at the crossroads of inflammation and repair in the eye","volume":"30","author":"da Silva","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2026.01.012_bb0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1159\/000529578","article-title":"The G-Protein-coupled formyl peptide receptor 2 promotes endothelial-mesenchymal transition in diabetic retinopathy","volume":"66","author":"Lou","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.tips.2026.01.012_bb0040","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ajpath.2023.05.020","article-title":"Anti-inflammatory and pro-resolving actions of the N-terminal peptides Ac2-26, Ac2-12, and Ac9-25 of annexin A1 on conjunctival goblet cell function","volume":"193","author":"Lyngstadaas","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2026.01.012_bb0045","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.3390\/cells10113170","article-title":"Annexin A1 mimetic peptide and piperlongumine: anti-inflammatory profiles in endotoxin-induced uveitis","volume":"10","author":"Girol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tips.2026.01.012_bb0050","first-page":"73","article-title":"Overexpression of annexin A1 inhibits pyroptosis and improves dry eye signs by regulating the TRIM72\/Nrf2\/HO-1 signaling pathway","author":"Zhang","year":"2025","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.tips.2026.01.012_bb0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.21037\/atm-21-3390","article-title":"LXA4 protects against blue-light induced retinal degeneration in human A2E-laden RPE cells and Balb-c mice","volume":"9","author":"Xie","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.tips.2026.01.012_bb0060","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1021\/acsptsci.4c00366","article-title":"Turn-adopting peptidomimetic as a formyl peptide receptor-1 antagonist","volume":"7","author":"De Fenza","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tips.2026.01.012_bb0065","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/02713683.2024.2363473","article-title":"Formyl peptide receptor 1 inhibits reparative angiogenesis and aggravates neuroretinal dysfunction in ischemic retinopathy","volume":"49","author":"Zheng","year":"2024","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.tips.2026.01.012_bb0070","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002135R","article-title":"Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation","volume":"35","author":"Gao","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2026.01.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201061RR","article-title":"Endothelial CYP2J2 overexpression restores the BRB via METTL3-mediated ANXA1 upregulation","volume":"36","author":"Zhao","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2026.01.012_bb0080","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/bph.15919","article-title":"Formylpeptide receptor 2: nomenclature, structure, signalling and translational perspectives: IUPHAR review 35","volume":"179","author":"Qin","year":"2022","journal-title":"Br. J. Pharmacol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:09:46Z","timestamp":1776118186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0165614726000167"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.01.012","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formyl peptide receptors as therapeutic targets in eye disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}